BIOMAT Database Logo BIOMAT Database Logo

Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination. 2006

Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077336 Caspofungin A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES. Cancidas,Caspofungin Acetate,Caspofungin MSD,L 743,872,L 743872,L-743,872,L-743872,MK 0991,MK-0991,L743,872,L743872,MK0991
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013158 Splenic Diseases Diseases involving the SPLEEN. Disease, Splenic,Diseases, Splenic,Splenic Disease

Related Publications

Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
November 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.
February 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation.
August 1991, Journal of internal medicine,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Comparison of the efficacy of combination and monotherapy with caspofungin and liposomal amphotericin B against invasive candidiasis.
May 2008, Saudi medical journal,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
July 2003, The Pediatric infectious disease journal,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
August 2004, The Journal of antimicrobial chemotherapy,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Caspofungin versus amphotericin B for invasive candidiasis.
March 2003, The New England journal of medicine,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.
December 2005, Haematologica,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
[Treatment of hepatosplenic candidiasis with liposomal amphotericin B in a patient with acute leukemia; a case report of the experience of use of liposomal amphotericin B].
June 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Bilgin Arda, and Nur Soyer, and Oguz Resat Sipahi, and Ozcan Hüdaverdi, and Meltem Isikgoz Tasbakan, and Guray Saydam, and Murat Tombuloglu
A mucormycosis case treated with a combination of caspofungin and amphotericin B.
September 2013, Journal de mycologie medicale,
Copied contents to your clipboard!